These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 36706775)
1. Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis. Trickey A; Fajardo E; Alemu D; Artenie AA; Easterbrook P Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):253-270. PubMed ID: 36706775 [TBL] [Abstract][Full Text] [Related]
2. Impact of Hepatitis B Virus Point-of-care DNA Viral Load Testing Compared With Laboratory-based Standard-of-care Approaches on Uptake of HBV Viral Load Testing, Treatment, and Turnaround Times: A Systematic Review and Meta-analysis. Gu S; Tao Y; Fan C; Dai Y; Li F; Conklin JL; Tucker JD; Chou R; Moody MA; Easterbrook P; Tang W Open Forum Infect Dis; 2024 Sep; 11(9):ofae483. PubMed ID: 39296343 [TBL] [Abstract][Full Text] [Related]
3. Reflex Hepatitis C Virus Viral Load Testing Following an Initial Positive Hepatitis C Virus Antibody Test: A Global Systematic Review and Meta-analysis. Tao Y; Tang W; Fajardo E; Cheng M; He S; Bissram JS; Hiebert L; Ward JW; Chou R; Rodríguez-Frías F; Easterbrook P; Tucker JD Clin Infect Dis; 2023 Oct; 77(8):1137-1156. PubMed ID: 37648655 [TBL] [Abstract][Full Text] [Related]
4. Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities. Ochodo EA; Olwanda EE; Deeks JJ; Mallett S Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013208. PubMed ID: 35266555 [TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
6. Decentralisation, integration, and task-shifting in hepatitis C virus infection testing and treatment: a global systematic review and meta-analysis. Oru E; Trickey A; Shirali R; Kanters S; Easterbrook P Lancet Glob Health; 2021 Apr; 9(4):e431-e445. PubMed ID: 33639097 [TBL] [Abstract][Full Text] [Related]
7. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis. Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Valencia BM; Bajis S; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J Lancet Gastroenterol Hepatol; 2022 May; 7(5):426-445. PubMed ID: 35303490 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies. le Roux SM; Odayar J; Sutcliffe CG; Salvatore PP; de Broucker G; Dowdy D; McCann NC; Frank SC; Ciaranello AL; Myer L; Vojnov L Lancet HIV; 2023 May; 10(5):e320-e331. PubMed ID: 37149292 [TBL] [Abstract][Full Text] [Related]
9. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review. Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339 [TBL] [Abstract][Full Text] [Related]
10. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis. Cunningham EB; Wheeler A; Hajarizadeh B; French CE; Roche R; Marshall AD; Fontaine G; Conway A; Bajis S; Valencia BM; Presseau J; Ward JW; Degenhardt L; Dore GJ; Hickman M; Vickerman P; Grebely J Int J Drug Policy; 2023 Jan; 111():103917. PubMed ID: 36542883 [TBL] [Abstract][Full Text] [Related]
11. A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study. Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J J Hepatol; 2023 Sep; 79(3):635-644. PubMed ID: 37116714 [TBL] [Abstract][Full Text] [Related]
12. Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility. MacIsaac MB; Whitton B; Anderson J; Cogger S; Vella-Horne D; Penn M; Weeks A; Elmore K; Pemberton D; Winter RJ; Papaluca T; Howell J; Hellard M; Stoové M; Wilson D; Pedrana A; Doyle JS; Clark N; Holmes JA; Thompson AJ Int J Drug Policy; 2024 Mar; 125():104317. PubMed ID: 38281385 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis. Tang W; Tao Y; Fajardo E; Reipold EI; Chou R; Tucker JD; Easterbrook P Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626411 [TBL] [Abstract][Full Text] [Related]
14. The impact of point-of-care hepatitis C testing in needle and syringe exchange programs on linkage to care and treatment uptake among people who inject drugs: An Australian pilot study. Howell J; Traeger MW; Williams B; Layton C; Doyle JS; Latham N; Draper B; Bramwell F; Membrey D; McPherson M; Roney J; Stoové M; Thompson AJ; Hellard ME; Pedrana A J Viral Hepat; 2022 May; 29(5):375-384. PubMed ID: 35274403 [TBL] [Abstract][Full Text] [Related]
15. Systematic review of the performance and clinical utility of point of care HIV-1 RNA testing for diagnosis and care. Agutu CA; Ngetsa CJ; Price MA; Rinke de Wit TF; Omosa-Manyonyi G; Sanders EJ; Graham SM PLoS One; 2019; 14(6):e0218369. PubMed ID: 31246963 [TBL] [Abstract][Full Text] [Related]
16. Impact of point-of-care HIV viral load and targeted drug resistance mutation testing on viral suppression among Kenyan pregnant and postpartum women: results from a prospective cohort study (Opt4Mamas). Patel RC; Oyaro P; Thomas KK; Basha GW; Wagude J; Mukui I; Brown E; Hassan SA; Kinywa E; Oluoch F; Odhiambo F; Oyaro B; Kingwara L; Karauki E; Yongo N; Otieno L; John-Stewart GC; Abuogi LL J Int AIDS Soc; 2023 Nov; 26(11):e26182. PubMed ID: 37938856 [TBL] [Abstract][Full Text] [Related]
17. Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination. Forns X; Colom J; García-Retortillo M; Quer JC; Lens S; Martró E; Domínguez-Hernández R; Casado MÁ; Buti M J Viral Hepat; 2022 Mar; 29(3):227-230. PubMed ID: 34806812 [TBL] [Abstract][Full Text] [Related]
18. Reducing Read Time of Point-of-Care Test Does Not Affect Detection of Hepatitis C Virus and Reduces Need for Reflex RNA. Smookler D; Vanderhoff A; Biondi MJ; Valencia J; Ryan P; Karkada J; Hong R; Sattar I; Mandel E; Gjevori M; Casey J; Fletcher D; Shah H; Hansen BE; Capraru C; Janssen HLA; Lazarus JV; Feld JJ Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1451-1458.e4. PubMed ID: 32763480 [TBL] [Abstract][Full Text] [Related]
19. Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study. Shilton S; Markby J; Japaridze M; Chihota V; Shadaker S; Gvinjilia L; Tsereteli M; Alkhazashvili M; Butsashvili M; Stvilia K; Ruiz RJ; Asatiani A; Adamia E; Easterbrook P; Khonelidze I; Gamkrelidze A Liver Int; 2022 Apr; 42(4):775-786. PubMed ID: 35129278 [TBL] [Abstract][Full Text] [Related]
20. POC CD4 Testing Improves Linkage to HIV Care and Timeliness of ART Initiation in a Public Health Approach: A Systematic Review and Meta-Analysis. Vojnov L; Markby J; Boeke C; Harris L; Ford N; Peter T PLoS One; 2016; 11(5):e0155256. PubMed ID: 27175484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]